Categories: BrainNews

IRLAB to present at Redeye Life Science Day on November 23, 2023

GOTHENBURG, SE / ACCESSWIRE / November 20, 2023 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, November 20, 2023 – IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson’s disease, today announced that the company will present at the Redeye Life Science Day 2023 on Thursday, November 23, 2023, in Stockholm, Sweden.

Gunnar Olsson, CEO, and Nicholas Waters, EVP and Head of R&D, will participate in the event. The company will give a 2-minute pitch and then participate in a 20-minute Q&A session at 10:00-10:20 CET on November 23, 2023. This event is held at Sergelkonferensen, Mäster Samuelsgatan 42 (ground floor, Redeye building), Stockholm, and is live-streamed.

More information can be found on the event webpage at: https://www.redeye.se/events/915984/redeye-life-science-day-2023

For more information:

Gunnar Olsson, CEO
Phone: +46 70 576 14 02
E-mail: gunnar.olsson@irlab.se

About IRLAB

IRLAB is discovering and developing a portfolio of transformative therapies targeting all stages of Parkinson’s disease. The company has its origin in Nobel Laureate Prof. Arvid Carlsson’s research group and the discovery of a connection between the brain’s neurotransmitters and CNS disorders. Mesdopetam (IRL790), in development for the treatment of levodopa-induced dyskinesias, has completed Phase IIb and is in preparation toward Phase III. Pirepemat (IRL752), is currently in Phase IIb, being evaluated for its effect on balance and fall frequency in Parkinson’s disease. In addition, the company is also progressing the three preclinical programs IRL942, IRL757, and IRL1117 towards Phase I studies. The pipeline is driven by IRLAB’s proprietary systems biology-based Integrative Screening Process (ISP) research platform. Headquartered in Sweden, IRLAB is listed on Nasdaq Stockholm (IRLAB A). For more information, please visit www.irlab.se .

Attachments

IRLAB to present at Redeye Life Science Day on November 23, 2023

SOURCE: IRLAB Therapeutics

View source version on accesswire.com:
https://www.accesswire.com/806937/irlab-to-present-at-redeye-life-science-day-on-november-23-2023

Staff

Recent Posts

Cadwell and Medical Informatics Corp. Announce Partnership to Bring Neurodiagnostic Data into Clinical Intelligence Ecosystem

KENNEWICK, Wash. and HOUSTON, Dec. 11, 2025 /PRNewswire/ -- Cadwell, a global leader in neurodiagnostic…

33 minutes ago

Thatch and ADP Simplify Small Business Healthcare with Seamless ICHRA Integration via RUN Powered by ADP

New embedded solution empowers more than 900,000 small businesses to offer flexible, affordable health coverage directly…

33 minutes ago

Suvoda IRT named a Leader in Everest Group’s RTSM PEAK Matrix®

CONSHOHOCKEN, Pa., Dec. 11, 2025 /PRNewswire/ -- Suvoda, a global clinical trial technology company, today announced…

33 minutes ago

TraceLink Supports UNICEF’s Traceability and Verification System (TRVST) to Advance Safe, Authentic Medicine Access Globally

TraceLink announced its support for UNICEF's Traceability and Verification System (TRVST), a global initiative improving…

33 minutes ago

Maison Law Study Reveals U.S. States With the Most–and Least–Stressful Commutes

VISALIA, Calif., Dec. 11, 2025 /PRNewswire/ -- Maison Law Accident & Injury Lawyers announces the…

33 minutes ago

SIGBEE AND TENNESSEE DEPARTMENT OF CORRECTION ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE EMPLOYEE ENGAGEMENT AND RETENTION

NASHVILLE, Tenn., Dec. 11, 2025 /PRNewswire/ -- The Tennessee Department of Correction (TDOC) has expanded its…

33 minutes ago